Live feed08:00:00·148dPRReleasevia QuantisnowNeuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and PremiumByQuantisnow·Wall Street's wire, on your screen.NEUP· Neuphoria Therapeutics Inc.Health Care
